Hospira announced the launch of its enhanced TheraDoc™ clinical surveillance system, used by hospitals to improve patient safety and prevent adverse events such as healthcare-associated infections. The enhanced TheraDoc system includes new features and functionalities designed to improve user satisfaction, reporting capabilities and work efficiency.Patient safety issues such as HAIs, adverse drug events and antimicrobial resistant infections have been linked to increased morbidity and mortality, and also can have an large financial impact.
The TheraDoc platform enhancements are designed to help hospitals meet and improve upon evolving quality metrics and national patient safety goals. The new platform also helps clinicians more easily identify antimicrobial resistant pathogens and drug-bug mismatches. Improvements to the TheraDoc Infection Control Assistant™module facilitate seamless electronic reporting of HAIs to the National Healthcare Safety Network (NHSN) and provide a new infection control dashboard for enhanced reporting, data comparison and benchmarking.
"The enhanced TheraDoc platform has added even more valuable tools available to our infection prevention team at Kootenai Health," said Lee Rieken R.N., C.I.C., infection prevention unit supervisor, Kootenai Health in Idaho. "The TheraDoc team continues to reach out to its customers and listen to their needs. As increasing demands are placed on the infection preventionist, the tools afforded them are increasing as well. I appreciate the dashboard within the new TheraDoc platform, because it is quite intuitive to use and helps us benchmark against NHSN."Stanley Pestotnik, M.S., R.Ph., general manager, TheraDoc, Hospira, said, "The enhanced TheraDoc system reflects Hospira's commitment to delivering innovative patient safety surveillance and clinical-decision support solutions."
The TheraDoc clinical surveillance platform is being demonstrated at Society for Healthcare Epidemiology of America (SHEA) booth #107 through April 4. For more information about TheraDoc, visit http://www.theradoc.com or call (801) 415-4400.
About Hospira
Hospira, Inc., is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost, and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at http://www.hospira.com.Hospira
No comments:
Post a Comment